SouthernWorldwide.com – The allure of saving money on prescription drugs at the pharmacy counter can be tempting, especially with offers of coupons that promise significant discounts. However, for individuals with insurance, accepting these manufacturer-sponsored coupons can lead to unforeseen costs and complexities.
Despite rising drug expenses, a recent study published in the Journal of the American Medical Association indicates a decline in the use of these coupons among patients with commercial insurance. This trend is observed even though manufacturers continue to offer them in substantial numbers.
So-Yeon Kang, the lead author of the study and an assistant professor at Georgetown University, noted that many insured patients still face affordability challenges. She described patients as being caught in the middle of disputes between payers and manufacturers.
Drug manufacturers provide these copay coupon cards, distributed online or at pharmacies, to enhance the competitiveness of their branded medications. Unlike discount card services that negotiate bulk pricing, these coupons offer immediate, short-term savings to consumers, encouraging the use of more expensive brand-name drugs over potentially cheaper generic alternatives.
Insurers argue that this practice unfairly burdens them with higher drug costs, leading to increased monthly premiums for all consumers, not just those using the coupons.
The question of whether to use manufacturer-sponsored drug coupons is not straightforward and depends heavily on individual circumstances.
1. For the Uninsured
If you do not have health insurance, these coupons can be a valuable tool for reducing out-of-pocket expenses, particularly when a generic option is unavailable.
The TrumpRx initiative, a federally funded platform, functions as a dashboard for prescription drug coupons, including those from manufacturers. While not all medications are covered, the portal can offer short-term savings for eligible drugs.
Michelle Long, a senior policy manager at KFF, acknowledges the potential benefits of TrumpRx and manufacturer coupons for the uninsured. She states that significant savings are possible for many individuals who rely on specific medications.
Read more : Trump Pardon Recipients Under Congressional Scrutiny for "Pay-to-Play" Concerns
However, it is important to be aware that TrumpRx lists a limited number of drugs compared to the vast array approved by the FDA. Furthermore, drug coupons typically have expiration dates, after which uninsured consumers may face the full cost of the medication.
2. For those with Commercial Health Insurance
The decision becomes more complex for individuals with commercial health insurance.
If a drug is not covered by your insurance plan or if you plan to pay out-of-pocket, a coupon might be beneficial. Otherwise, caution is advised.
Insurance coverage for certain drug classes, such as GLP-1 obesity medications, can vary significantly. Kang’s research revealed a sharp decrease in coupon usage for these drugs among commercially insured patients, from 54.6% in 2017 to just 2.5% in 2024, despite an overall rise in their use.
This shift is attributed to an increase in patients paying cash for these medications as prices decrease, coupled with insurers’ reluctance to cover them and manufacturers’ focus moving from coupon distribution to broader marketing strategies.
3. Anticipating High Medical Costs
If you have insurance and expect to reach your annual deductible through medical visits and treatments, considering the use of coupons might be worthwhile.
While coupons reduce immediate out-of-pocket pharmacy costs, the value of the coupon is generally not counted towards your deductible by your insurer. Therefore, using a coupon is advisable only if there is no generic alternative and if you are certain you would meet your deductible regardless.
4. Low Overall Medical Costs with Insurance
For individuals with insurance and low expected medical expenses, it is almost always better to decline the coupon.
Unless the medication is not covered by your insurance, using coupons can lead to higher indirect costs. It is often more advantageous to accumulate spending towards your deductible.
Be aware of “copay adjustment programs” that insurers implement to discourage coupon use. These programs typically manifest in two forms, according to Long.
“Copay accumulators” allow the full value of drug coupons to be used, but this amount does not count towards the patient’s deductible or out-of-pocket maximums. This can prolong the time it takes for patients to reach the threshold where their insurance begins covering prescriptions and other medical services, potentially leading them to pay the full drug cost eventually.
“Copay maximizers” employ a similar mechanism, preventing coupon value from contributing to deductibles. These programs often involve a third party that adjusts a patient’s copayments throughout the year to align with the value of manufacturer coupons.
Insurers may present these programs with appealing names like “Employee Savings Program,” which sound beneficial but ultimately diminish the value of coupons for consumers. While initial savings may be observed at the pharmacy, long-term costs could increase.
5. Medicaid and Medicare Beneficiaries
Individuals enrolled in Medicare and Medicaid are not permitted to use manufacturer-sponsored coupons.
This prohibition stems from a federal anti-kickback law, which deems it illegal to offer anything of value to influence a purchase that will be covered by a federal health care program. The law also covers remuneration, including the waiver of copays and selling products below fair-market value.
Manufacturer drug coupons fall directly under these regulations.
Some states, including California and Massachusetts, have laws that restrict or prohibit the use of manufacturer drug coupons when a generic alternative is available, illustrating the ongoing tension between manufacturers, health plans, and governmental bodies.
KFF Health News is a national newsroom dedicated to producing in-depth journalism on health-related topics. It operates as one of the core programs of KFF, an independent entity providing research, polling, and journalism on health policy.
